Overall, our study explored the different effects of IDO and Treg cells on ovarian cancer cells under hypoxic conditions, and suggests that targeting IDO and Treg cels may constitute a suitable therapeutic route for ovarian cancer. The gene discussed is IDO1; the disease is ovarian cancer.